Public Company News
GoldenHome Dazzles at KBIS 2025 with Innovative Custom Cabinetry and Closet Solutions
LAS VEGAS, Feb. 25, 2025 /PRNewswire/ -- GoldenHome, a global leader in custom home solutions, is showcasing its latest collection of cabinets and closets featuring smart and contemporary design aesthetics at the 2025 Kitchen and Bath Industry Show (KBIS) inLas Vegas. This year marks GoldenHome's...
2025-02-26 02:00
2471
Eason Technology Securres HK $1.5 Million in Funding to Accelerate Blockchain Intellectual Property Protection Development
HONG KONG, Feb. 25, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason" or the "Company") (NYSE American: DXF), a company engaged in real estate operation management and investment, and digital technology security business, today announced a transaction in which Renying Capital have invested H...
2025-02-25 22:40
3874
Gaudio Lab Returns to SXSW with an Immersive "Audio-Driven Campsite" Experience
AUSTIN, Texas, Feb. 25, 2025 /PRNewswire/ -- Gaudio Lab, a leading innovator in AI-powered audio and spatial sound technology, will return to SXSW 2025, unveiling an immersive "audio-driven campsite" experience. This marks the company's second consecutive year at SXSW, reinforcing its position as...
2025-02-25 22:00
2799
SunCar Technology Addresses National Automotive Circulation Industry Forum, Showcasing Digital Solutions for Dealers
NEW YORK, Feb. 25, 2025 /PRNewswire/ -- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA), an innovative leader in auto e-insurance and cloud-based B2B auto services inChina, participated in the National Automotive Circulation Industry New Year Forum and Consumer Promotion Co...
2025-02-25 21:45
3295
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
* SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials inAustralia and New Zealand, with interim results expected by 2026 * Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding support from CEPI * SK bioscience will expand its vaccin...
2025-02-25 21:00
3772
CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China
SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, "CARsgen Therapeutics"), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces reaching agreements with an investment fund m...
2025-02-25 21:00
2842
RoboSense Achieves Milestone with Production and Delivery of Its 1 Millionth LiDAR
SHENZHEN, China, Feb. 25, 2025 /PRNewswire/ -- On February 21, RoboSense (2498.HK), an AI-driven robotics technology company that supplies industry-leading incremental components and solutions for the robotics market, held a ceremony inShenzhen to celebrate the production of its 1 millionth LiDAR...
2025-02-25 20:34
4921
Euro Tech Holdings Company Limited Reports Contracts Awarded to PACT
HONG KONG, Feb. 25, 2025 /PRNewswire/ -- Euro Tech Holdings Company Limited (Nasdaq: CLWT) today announced that its majority-owned subsidiary, YixingPACT Environmental Technology Company Ltd. ("PACT") has recently been awarded two contracts worth approximatelyUS$2.2 million in total. One project ...
2025-02-25 20:00
2980
Baidu Acquires JOYY's Live Streaming Business in China
BEIJING, Feb. 25, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"), a leading AI company with strong Internet foundation, today announced that Baidu entered into agreements with JOYY Inc and acquired the video-based entertainment live ...
2025-02-25 19:00
2925
China Yuchai International Announces Unaudited 2024 Second Half-Year and Full Year Financial Results
SINGAPORE, Feb. 25, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), wishes to announce to...
2025-02-25 19:00
4217
MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment
* Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued progression as planned * MRX-4 Injection followed by Contezolid Tablets demonstrated favorable safety and efficacy profiles in patients with...
2025-02-25 18:44
3103
WuXi XDC and LigaChem Biosciences Strengthen Partnership with Expanded MOU to Accelerate ADC Development
SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, today announced the si...
2025-02-25 18:34
2294
HUYA Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 18, 2025
-Earnings Webinar Scheduled for 6:00 a.m. ET on March 18, 2025- GUANGZHOU, China, Feb. 25, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform inChina, today announced that it will report its fourth quarter and fiscal year 2024 unaudited ...
2025-02-25 18:00
2301
Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 25, 2025 GUANGZHOU, China, Feb. 25, 2025 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leadingChina-based beauty group, today announced its unaudited financial results for the fourth quarter ...
2025-02-25 18:00
3021
ZTO to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 18, 2025 U.S. Eastern Time
SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"), a leading and fast-growing express delivery company in China, today announced that it will release its unaudited financial results for the fourth quarter endedDecember 31, 2024 a...
2025-02-25 17:00
2791
ATRenew to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform in China, today announced that it plans to release its unaudited financial results for the fourth quarter a...
2025-02-25 16:00
2448
ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
* 6.3% Increase in Full Year 2024 Revenue Compared to Prior Year * 13.0% Full Year 2024 Gross Margin Compared to 16.6% in 2023 * Full Year 2024 Net Earnings of NT$1.95 per Basic Common Share or US$1.19 per Basic ADS Compared to Net Earnings ofNT$2.60 per Basic Common Share or US$1.59 per Bas...
2025-02-25 16:00
2708
How 51Talk is Redefining Online Education Through AI--from the Boardroom to the Classroom
SINGAPORE, Feb. 25, 2025 /PRNewswire/ -- 51Talk, an online English language education platform, has announced plans to launch a comprehensive, AI-powered systems upgrade across its business operations within the coming months. Partnering with top tier global AI service providers, the company desc...
2025-02-25 13:56
3145
CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA
* Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results supportsugemalimab in combination with chemotherapy as a new standard first-line treatmentfor patients wit...
2025-02-25 12:10
3347
Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
HONG KONG, Feb. 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investi...
2025-02-25 09:13
2436
Week's Top Stories
Most Reposted
Visa Partners with OpenAI to Power the Next Generation of AI Commerce
[Picked up by 306 media titles]
2026-06-11 09:30QuettaFlow Technologies Strengthens Global Strategic Alliance with Lead Wealth and Showcases VasEdge at COMPUTEX Taipei 2026
[Picked up by 296 media titles]
2026-06-11 10:00
HKC, ANTGAMER, KOORUI Make Strong Debut at COMPUTEX 2026 with World-First Display Innovations
[Picked up by 280 media titles]
2026-06-10 11:13
Changan Group Unveils Its In-house Developed ADAS -- SDA Pilot
[Picked up by 274 media titles]
2026-06-14 18:19
Six Regional Organisations Sign MoU to Strengthen Asia's Dengue Response as Cases Rise
[Picked up by 272 media titles]
2026-06-15 19:30Most Read
Visa Partners with OpenAI to Power the Next Generation of AI Commerce
2026-06-11 09:30
8207
Sun Life Asia Financial Resilience Index: Financial Security Declines as Cost-of-Living Pressure Bites
2026-06-09 10:00
8068
51Talk Online Education Group Announces First Quarter 2026 Results
2026-06-12 19:00
7673
